BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22797009)

  • 21. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
    Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
    J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine leukemia virus (MLV) P50 protein induces cell transformation via transcriptional regulatory function.
    Akkawi C; Feuillard J; Diaz FL; Belkhir K; Godefroy N; Peloponese JM; Mougel M; Laine S
    Retrovirology; 2023 Sep; 20(1):16. PubMed ID: 37700325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HELZ2: a new, interferon-regulated, human 3'-5' exoribonuclease of the RNB family is expressed from a non-canonical initiation codon.
    Huntzinger E; Sinteff J; Morlet B; Séraphin B
    Nucleic Acids Res; 2023 Sep; 51(17):9279-9293. PubMed ID: 37602378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets.
    Roberto M; Arrivi G; Di Civita MA; Barchiesi G; Pilozzi E; Marchetti P; Santini D; Mazzuca F; Tomao S
    Front Oncol; 2023; 13():1154581. PubMed ID: 37035150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMG1 interacts with NOP14 to regulate the growth, migration, and invasion of melanoma cells via the Wnt/β-catenin pathway.
    Li J; Zhao R; Guo Y; Fang R
    Transl Cancer Res; 2020 May; 9(5):3669-3679. PubMed ID: 35117729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact.
    Gutiérrez ML; Muñoz-Bellvís L; Orfao A
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.
    Hofschröer V; Najder K; Rugi M; Bouazzi R; Cozzolino M; Arcangeli A; Panyi G; Schwab A
    Front Pharmacol; 2020; 11():586599. PubMed ID: 33841132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma.
    Schnipper J; Dhennin-Duthille I; Ahidouch A; Ouadid-Ahidouch H
    Front Pharmacol; 2020; 11():568993. PubMed ID: 33178018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.
    Liu X; Haniff HS; Childs-Disney JL; Shuster A; Aikawa H; Adibekian A; Disney MD
    J Am Chem Soc; 2020 Apr; 142(15):6970-6982. PubMed ID: 32233464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma.
    Gu Y; Feng Q; Liu H; Zhou Q; Hu A; Yamaguchi T; Xia S; Kobayashi H
    Heliyon; 2019 Aug; 5(8):e02378. PubMed ID: 31489384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway.
    Li J; Fang R; Wang J; Deng L
    Braz J Med Biol Res; 2018 Nov; 52(1):e7952. PubMed ID: 30484495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist Binding to Chemosensory Receptors: A Systematic Bioinformatics Analysis.
    Fierro F; Suku E; Alfonso-Prieto M; Giorgetti A; Cichon S; Carloni P
    Front Mol Biosci; 2017; 4():63. PubMed ID: 28932739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revisiting olfactory receptors as putative drivers of cancer.
    Ranzani M; Iyer V; Ibarra-Soria X; Del Castillo Velasco-Herrera M; Garnett M; Logan D; Adams DJ
    Wellcome Open Res; 2017 Feb; 2():9. PubMed ID: 28492065
    [No Abstract]   [Full Text] [Related]  

  • 34. CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.
    Guo JC; Li J; Zhou L; Yang JY; Zhang ZG; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP
    Oncotarget; 2016 Sep; 7(38):62006-62018. PubMed ID: 27542220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
    Weygant N; Ge Y; Qu D; Kaddis JS; Berry WL; May R; Chandrakesan P; Bannerman-Menson E; Vega KJ; Tomasek JJ; Bronze MS; An G; Houchen CW
    Cancer Res; 2016 Jul; 76(14):4090-9. PubMed ID: 27287716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.
    Olmedillas López S; García-Olmo DC; García-Arranz M; Guadalajara H; Pastor C; García-Olmo D
    Int J Mol Sci; 2016 Apr; 17(4):484. PubMed ID: 27043547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway.
    Lei JJ; Peng RJ; Kuang BH; Yuan ZY; Qin T; Liu WS; Guo YM; Han HQ; Lian YF; Deng CC; Zhang HJ; Chen LZ; Feng QS; Xu M; Feng L; Bei JX; Zeng YX
    Oncotarget; 2015 Sep; 6(28):25701-14. PubMed ID: 26213846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-exome sequencing identifies OR2W3 mutation as a cause of autosomal dominant retinitis pigmentosa.
    Ma X; Guan L; Wu W; Zhang Y; Zheng W; Gao YT; Long J; Wu N; Wu L; Xiang Y; Xu B; Shen M; Chen Y; Wang Y; Yin Y; Li Y; Xu H; Xu X; Li Y
    Sci Rep; 2015 Mar; 5():9236. PubMed ID: 25783483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
    Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
    Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96.
    Feng J; Yu J; Pan X; Li Z; Chen Z; Zhang W; Wang B; Yang L; Xu H; Zhang G; Xu Z
    Oncotarget; 2014 Jul; 5(14):5832-44. PubMed ID: 25071021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.